Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population

被引:99
作者
Chida, M
Yokoi, T
Fukui, T
Kinoshita, M
Yokota, J
Kamataki, T
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Div Pharmacobiodynam,Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Otsuka Pharmaceut Co Ltd, Ostuka Assay Labs, Tokushima 7710130, Japan
[3] Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 1040045, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 09期
关键词
polymorphism; PCR-RFLP; cytochrome P450;
D O I
10.1111/j.1349-7006.1999.tb00832.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interindividual variability of the activity of CYP1A2 may be expected to affect cancer susceptibility, since the enzyme is capable of activating several carcinogens. In the present study, we found three new polymorphisms in the 5'-flanking region (CYP1A2/B) and intron 1 (CYP1A2/C and CYP1A2/D) of CYP1A2 in Japanese by using polymerase chain reaction-single strand conformation polymorphism. We developed methods to detect these polymorphisms by polymerase chain reaction-restriction fragment length polymorphism and performed a population study (159 subjects) to estimate the frequencies of the alleles, The frequencies of the CYP1A2/A (adenine), CYP1A2/B (thymine-deleted), CYP1A2/C (guanine) and CYP1A2/D (adenine) variants were 21.1, 42.0, 8.2 and 61.3%, respectively. The results of family study supported the idea that these CYP1A2 genotypes are inherited with an autosomal codominant transmission.
引用
收藏
页码:899 / 902
页数:4
相关论文
共 18 条
[1]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[2]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[3]  
BUTLER MA, 1989, CANCER RES, V49, P25
[4]  
HAMMONS GJ, 1985, CANCER RES, V45, P3578
[5]   HUMAN CYP1A2 - SEQUENCE, GENE STRUCTURE, COMPARISON WITH THE MOUSE AND RAT ORTHOLOGOUS GENE, AND DIFFERENCES IN LIVER 1A2 MESSENGER-RNA EXPRESSION [J].
IKEYA, K ;
JAISWAL, AK ;
OWENS, RA ;
JONES, JE ;
NEBERT, DW ;
KIMURA, S .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) :1399-1408
[6]   CAFFEINE AS A METABOLIC PROBE - EXPLORATION OF THE ENZYME-INDUCING EFFECT OF CIGARETTE-SMOKING [J].
KALOW, W ;
TANG, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (01) :44-48
[7]  
KAMATAKI T, 1983, MOL PHARMACOL, V24, P146
[8]  
MCMANUS ME, 1990, CANCER RES, V50, P3367
[9]   POLYMORPHIC METABOLISM OF THE CARCINOGEN 2-ACETYLAMINOFLUORENE IN HUMAN-LIVER MICROSOMES [J].
MINCHIN, RF ;
MCMANUS, ME ;
BOOBIS, AR ;
DAVIES, DS ;
THORGEIRSSON, SS .
CARCINOGENESIS, 1985, 6 (12) :1721-1724
[10]   Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene:: Effect on the CYP1A2 inducibility in humans [J].
Nakajima, M ;
Yokoi, T ;
Mizutani, M ;
Kinoshita, M ;
Funayama, M ;
Kamataki, T .
JOURNAL OF BIOCHEMISTRY, 1999, 125 (04) :803-808